Benzidine

Benzidine

SCHEMBL720393

Nc1ccc(-c2ccc(N)cc2)cc1.Nc1ccc(-c2ccc(N)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 1.00
ALDH1A1 P00352 6/20 1.00
TDP1 Q9NUW8 5/20 1.00
TP53 P04637 2/20 1.00
HSD17B10 Q99714 3/20 0.73
TAAR1 Q96RJ0 2/20 0.73
MEN1 O00255 3/20 0.73
MAPT P10636 3/20 0.73
KMT2A Q03164 3/20 0.73
KIF11 P52732 1/20 0.58
APP P05067 2/20 0.56
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
CA14 Q9ULX7 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
KDM4E B2RXH2 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2024128 1.00 CYP3A4 (1.00) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL258287 1.00 CYP3A4 (1.00) CYP3A4ALDH1A1TDP1TP53HSD17B10
Benzidine SCHEMBL5140469 1.00 CYP3A4 (1.00) CYP3A4ALDH1A1TDP1TP53HSD17B10
Benzidine SCHEMBL29021 1.00 CYP3A4 (1.00) CYP3A4ALDH1A1TDP1TP53HSD17B10
Benzidine SCHEMBL25274606 0.96 CYP3A4 (0.92) CYP3A4ALDH1A1TDP1TP53HSD17B10
Benzidine SCHEMBL6052806 0.96 CYP3A4 (0.92) CYP3A4ALDH1A1TDP1TP53HSD17B10
Benzidine SCHEMBL11345971 0.96 CYP3A4 (0.92) CYP3A4ALDH1A1TDP1TP53HSD17B10
Benzidine SCHEMBL9067542 0.96 CYP3A4 (0.92) CYP3A4ALDH1A1TDP1TP53HSD17B10
Benzidine SCHEMBL22773196 0.96 CYP3A4 (0.92) CYP3A4ALDH1A1TDP1TP53HSD17B10
Benzidine SCHEMBL570771 0.96 CYP3A4 (0.92) CYP3A4ALDH1A1TDP1TP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11495744-B2 Organic semiconductor composition, organic thin film, and organic thin film transistor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2022-11-08 US disclosed
US-20200136061-A1 Organic Semiconductor Composition, Organic Thin Film, and Organic Thin Film Transistor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2020-04-30 US disclosed
EP-3240056-B1 ORGANIC SEMICONDUCTOR LIQUID COMPOSITION AND METHOD OF PRODUCING ORGANIC SEMICONDUCTOR ELEMENT USING SAID COMPOSITION FUJIFILM CORP (JP) 2020-04-22 EP disclosed
EP-3608981-A1 ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC THIN FILM AND ORGANIC THIN FILM TRANSISTOR Nippon Kayaku Kabushiki Kaisha (JP) 2020-02-12 EP disclosed
CN-110272552-A A kind of preparation method of graphite sintering Kapton 青岛科思姆新材料有限公司 2019-09-24 CN disclosed
US-10341475-B2 Display unit, method of manufacturing the same, and electronic apparatus SONY CORPORATION (JP) 2019-07-02 US disclosed
US-10158088-B2 Organic semiconductor liquid composition, organic semiconductor element, and method for preparing organic semiconductor element FUJIFILM CORPORATION (JP) 2018-12-18 US disclosed
US-10134812-B2 Electronic device, image display device, and sensor to improve charge injection efficiency SONY CORPORATION (JP) 2018-11-20 US disclosed
US-20180191880-A1 DISPLAY UNIT, METHOD OF MANUFACTURING THE SAME, AND ELECTRONIC APPARATUS SONY CORPORATION (JP) 2018-07-05 US disclosed
US-10008671-B2 Organic thin-film transistor and method for manufacturing same FUJIFILM CORPORATION (JP) 2018-06-26 US disclosed
EP-2321376-A1 HOLE TRANSPORT MATERIALS HAVING A SULFUR-CONTAINING GROUP Universal Display Corporation (US) 2011-05-18 EP disclosed
EP-2313362-A1 HOLE TRANSPORT MATERIALS CONTAINING TRIPHENYLENE Universal Display Corporation (US) 2011-04-27 EP disclosed
US-7884357-B2 Organic electronic device, method for production thereof, and organic semiconductor molecule SONY CORPORATION (JP) 2011-02-08 US disclosed
US-20100314611-A1 ELECTRODE COVERING MATERIAL, ELECTRODE STRUCTURE AND SEMICONDUCTOR DEVICE SONY CORPORATION (JP) 2010-12-16 US disclosed
US-20100264404-A1 ORGANIC ELECTRONIC DEVICE, METHOD FOR PRODUCTION THEREOF, AND ORGANIC SEMICONDUCTOR MOLECULE SONY CORPORATION (JP) 2010-10-21 US disclosed
EP-2091077-A1 ELECTRODE COATING MATERIAL, ELECTRODE STRUCTURE AND SEMICONDUCTOR DEVICE Sony Corporation (JP) 2009-08-19 EP disclosed
US-20080012010-A1 ORGANIC ELECTRONIC DEVICE, METHOD FOR PRODUCTION THEREOF, AND ORGANIC SEMICONDUCTOR MOLECULE SONY CORPORATION (JP) 2008-01-17 US disclosed
US-6258469-B1 LIGHT EMITTING DIODES SIEMENS AKTIENGESELLSCHAFT (DE) 2001-07-10 US disclosed
US-5976743-A Electrophotographic photoreceptor MATSUSHITA ELECTRIC WORKS, LTD. (JP) 1999-11-02 US disclosed
US-5376169-A Nonaqueous solvent, pigment, resin and at least one additive from alginates and borneols MINOLTA CAMERA KABUSHIKI KAISHA (JP) 1994-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10158088-B2 Organic semiconductor liquid composition, organic semiconductor element, and method for preparing organic semiconductor element SLCO2A1, SLCO4C1, SLCO2B1 CYP3A4 2969/4885ALDH1A1 2733/4885TDP1 1368/4885
US-10008671-B2 Organic thin-film transistor and method for manufacturing same TET1, FTO, TET2 CYP3A4 896/4885ALDH1A1 2895/4885TDP1 395/4885
US-20100314611-A1 ELECTRODE COVERING MATERIAL, ELECTRODE STRUCTURE AND SEMICONDUCTOR DEVICE EPCAM, PIEZO1, KCNN4 CYP3A4 2856/4885ALDH1A1 4535/4885TDP1 2578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.